Banco Bradesco's Investment Firm Signs Agreement with Rede D'Or, Boosts Healthcare Portfolio
ByAinvest
Friday, Sep 19, 2025 12:26 am ET2min read
BBD--
The strategic partnership is expected to bolster Banco Bradesco's presence in the healthcare sector, a significant addition to its existing portfolio of banking products and services. This move comes amidst a period of increased institutional interest in Banco Bradesco, with several key investors and analysts expressing positive sentiments about the bank's prospects.
In the first quarter of 2025, AQR Capital Management LLC increased its stake in Banco Bradesco by 75.9%, now holding over 5 million shares valued at approximately $11.26 million [1]. Citigroup upgraded Banco Bradesco's rating from "hold" to "buy," with three analysts rating the stock as a buy and a consensus price target of $2.40 [1]. Other institutional investors, such as Aprio Wealth Management LLC, Graham Capital Management L.P., Vident Advisory LLC, Earnest Partners LLC, and Samalin Investment Counsel LLC, also increased their stakes in the bank [1].
Banco Bradesco recently announced a monthly dividend payment of $0.0035, marking an increase from its previous monthly dividend of $0.00, with an annualized yield of 1.3% [1]. The company's latest earnings report showed $0.10 earnings per share for the quarter, hitting analysts' consensus estimates of $0.10 [1]. Analysts expect Banco Bradesco to post 0.37 earnings per share for the current fiscal year.
The stock's performance has been robust, with shares opening at $3.13 on Thursday and reaching a 1-year high of $3.24. The company has a market capitalization of $33.26 billion, a PE ratio of 8.93, a PEG ratio of 0.43, and a beta of 0.76 [1]. The company's debt-to-equity ratio is 0.63, and its quick ratio is 1.11, indicating strong financial health.
The recent strategic partnership and positive analyst ratings suggest a favorable outlook for Banco Bradesco. As the company continues to expand its services and attract institutional investors, it remains an attractive option for investors seeking exposure to the Brazilian banking sector.
BBDO--
Banco Bradesco S.A.'s indirectly controlled investment firm, Atlântica Hospitais e Participações S.A., signed an investment agreement with Rede D'Or São Luiz S.A. Group to include Hospital Glória D'Or in the Atlântica D'Or network. The partnership will maintain a 50.01% stake held by Rede D'Or and 49.99% by Atlântica. The transaction is subject to regulatory approvals and other conditions of the agreement. Since the announcement, BBD shares have soared by 9.06%. Banco Bradesco offers various banking products and services to individuals, corporates, and businesses in Brazil and globally.
Banco Bradesco S.A.'s indirectly controlled investment firm, Atlântica Hospitais e Participações S.A., has signed an investment agreement with Rede D'Or São Luiz S.A. Group to include Hospital Glória D'Or in the Atlântica D'Or network. The partnership will maintain a 50.01% stake held by Rede D'Or and 49.99% by Atlântica. The transaction is subject to regulatory approvals and other conditions of the agreement. Since the announcement, BBD shares have soared by 9.06%.The strategic partnership is expected to bolster Banco Bradesco's presence in the healthcare sector, a significant addition to its existing portfolio of banking products and services. This move comes amidst a period of increased institutional interest in Banco Bradesco, with several key investors and analysts expressing positive sentiments about the bank's prospects.
In the first quarter of 2025, AQR Capital Management LLC increased its stake in Banco Bradesco by 75.9%, now holding over 5 million shares valued at approximately $11.26 million [1]. Citigroup upgraded Banco Bradesco's rating from "hold" to "buy," with three analysts rating the stock as a buy and a consensus price target of $2.40 [1]. Other institutional investors, such as Aprio Wealth Management LLC, Graham Capital Management L.P., Vident Advisory LLC, Earnest Partners LLC, and Samalin Investment Counsel LLC, also increased their stakes in the bank [1].
Banco Bradesco recently announced a monthly dividend payment of $0.0035, marking an increase from its previous monthly dividend of $0.00, with an annualized yield of 1.3% [1]. The company's latest earnings report showed $0.10 earnings per share for the quarter, hitting analysts' consensus estimates of $0.10 [1]. Analysts expect Banco Bradesco to post 0.37 earnings per share for the current fiscal year.
The stock's performance has been robust, with shares opening at $3.13 on Thursday and reaching a 1-year high of $3.24. The company has a market capitalization of $33.26 billion, a PE ratio of 8.93, a PEG ratio of 0.43, and a beta of 0.76 [1]. The company's debt-to-equity ratio is 0.63, and its quick ratio is 1.11, indicating strong financial health.
The recent strategic partnership and positive analyst ratings suggest a favorable outlook for Banco Bradesco. As the company continues to expand its services and attract institutional investors, it remains an attractive option for investors seeking exposure to the Brazilian banking sector.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet